Can you be denied on closing day?

Written by Admin | Last Updated: July 2026

Shareholders can be legally compelled to sell their shares during corporate takeovers, mergers, or acquisitions if specific statutory thresholds and governance rules are met. In public company acquisitions, if a majority buyer or acquiring corporation successfully executes a tender offer and acquires a supermajority stake—typically ninety percent or more of the outstanding voting shares—they can invoke statutory short-form merger laws, known as drag-along rights or compulsory squeeze-out acquisitions. These legal provisions allow the acquiring entity to force remaining minority shareholders to surrender their shares for the exact same cash or stock consideration offered in the buyout. While minority investors retain legal rights to appraise fair market value through the courts if they believe the offer is inadequate, they cannot ultimately block the structural transaction or refuse to sell their equity.

Related FAQs

Yes, you can rent a car in Brazil using a valid driver's license issued in the United States.

Yes, in late 2023, DB Insurance, a leading South Korean insurance provider, entered into a definitive agreement to acquire a majority stake in Fortegra, a specialty insurance firm based in the United States.

Vesta Realty manages security deposits by adhering strictly to state-specific real estate trust accounting regulations and landlord-tenant laws governing tenant financial holdings.

VICI Properties generates its revenue primarily as a specialized real estate investment trust (REIT) focused on owning, acquiring, and managing market-leading experiential, hospitality, and entertainment destinations.

Vinton County National Bank (widely known as VCNB) has been operating as an independent community financial institution for well over a century, having been officially chartered and opened for business in the year 1887 in McArthur, Ohio.

Executive compensation for the chief executive officer guiding DexCom, Inc. (a leader in continuous glucose monitoring technology for diabetes management) reflects high-growth medical device sector benchmarks.